Results 281 to 290 of about 100,300 (318)
Some of the next articles are maybe not open access.
The American Journal of Cardiology, 2007
Drug-eluting stents (DESs) held the promise of mitigating, if not abolishing, in-stent restenosis. This led to early adoption and high penetration of DES use in percutaneous coronary intervention (PCI). Outcomes have not demonstrated an improvement in the hard end points of death and myocardial infarction with these devices, but repeat procedures for ...
Tina L Pinto, Slottow, Ron, Waksman
openaire +2 more sources
Drug-eluting stents (DESs) held the promise of mitigating, if not abolishing, in-stent restenosis. This led to early adoption and high penetration of DES use in percutaneous coronary intervention (PCI). Outcomes have not demonstrated an improvement in the hard end points of death and myocardial infarction with these devices, but repeat procedures for ...
Tina L Pinto, Slottow, Ron, Waksman
openaire +2 more sources
Current Problems in Cardiology, 2006
The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty.
Amar M, Salam +2 more
openaire +2 more sources
The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty.
Amar M, Salam +2 more
openaire +2 more sources
Drug Eluting Stents and Beyond
Current Pharmaceutical Design, 2008The present review discusses the mechanism of late stent thrombosis and its distinction from restenosis and summarizes the advisory note issued by FDA on the proper usage of different treatments available for atherosclerosis. In light of the latest developments, a plethora of new stents have been and continue to be developed globally. Hence, there is a
Ashish, Rastogi, Salomon, Stavchansky
openaire +2 more sources
Drug-eluting stent thrombosis: current and future perspectives
Cardiovascular Intervention and Therapeutics, 2021S. Kuramitsu +9 more
semanticscholar +1 more source
Drug-eluting stents: a reappraisal
Heart, 2010The introduction of drug-eluting stents (DES) in 2002 revolutionised the field of percutaneous coronary intervention (PCI), by significantly reducing rates of restenosis when compared to bare-metal stents (BMS).1 Following this there was a rapid and unprecedented uptake in their use, such that within a matter of years they were used in approximately 80–
Garg, Scot, Serruys, PWJC (Patrick)
openaire +2 more sources
Dimensions of Critical Care Nursing, 2007
Coronary artery disease is the number 1 killer of Americans. There are many efforts underway to prevent and treat this life-threatening disease. One such treatment is the placement of drug-eluting stents. However, recent reports that show an increased risk of potentially life-threatening complications associated with drug-eluting stents have surfaced ...
openaire +2 more sources
Coronary artery disease is the number 1 killer of Americans. There are many efforts underway to prevent and treat this life-threatening disease. One such treatment is the placement of drug-eluting stents. However, recent reports that show an increased risk of potentially life-threatening complications associated with drug-eluting stents have surfaced ...
openaire +2 more sources
American Heart Journal, 2007
Currently, little data are available on the management of drug-eluting stent (DES) restenosis. Drug resistance may play a role in its etiology.We identified all cases of either sirolimus-eluting or paclitaxel-eluting stent restenosis treated with repeated DES implantation.
Cosgrave John +11 more
openaire +4 more sources
Currently, little data are available on the management of drug-eluting stent (DES) restenosis. Drug resistance may play a role in its etiology.We identified all cases of either sirolimus-eluting or paclitaxel-eluting stent restenosis treated with repeated DES implantation.
Cosgrave John +11 more
openaire +4 more sources
Mechanisms of drug-eluting stent restenosis
Cardiovascular Intervention and Therapeutics, 2020J. Aoki, K. Tanabe
semanticscholar +1 more source
Journal of the American College of Cardiology, 2018
Junjie Zhang +22 more
semanticscholar +1 more source
Junjie Zhang +22 more
semanticscholar +1 more source